Log In
BCIQ
Print this Print this
 

coltuximab ravtansine (SAR3419)

  Manage Alerts
Collapse Summary General Information
Company ImmunoGen Inc.
DescriptionHumanized CD19 mAb linked to ImmunoGen's DM4 cytotoxic agent
Molecular Target CD19
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today